Management of Insomnia in Elderly Patients

Introduction to Alternative Therapies

The American Academy of Sleep Medicine recommends switching to a short-acting benzodiazepine receptor agonist (BzRA) such as zolpidem 5mg or eszopiclone 1mg at bedtime, or considering ramelteon 8mg if sleep-onset is the primary issue, for elderly patients with insomnia when trazodone 100mg fails 1, 2, 3

For sleep-onset insomnia, the American Academy of Sleep Medicine suggests zolpidem 5mg at bedtime, which reduces sleep latency effectively, or ramelteon 8mg at bedtime, a melatonin receptor agonist with minimal adverse effects 1, 2
For sleep-maintenance insomnia, eszopiclone 1mg at bedtime is recommended, as it is intermediate-acting and approved for both sleep onset and maintenance with no short-term usage restriction 1, 2
The VA/DOD guidelines advise against trazodone for chronic insomnia, finding no differences in sleep efficiency between trazodone (50-150mg) and placebo, and the American Academy of Sleep Medicine explicitly recommends against trazodone for insomnia treatment 4

All BzRAs must be started at the lowest available dose in elderly patients due to increased sensitivity to peak drug effects and reduced clearance, according to the Journal of the American Geriatrics Society 7, 1, 2
The American Academy of Sleep Medicine recommends zolpidem 5mg (not 10mg), eszopiclone 1mg (max 2mg), and zaleplon 5mg (not 10mg) for elderly patients 1, 2

Cognitive Behavioral Therapy for Insomnia (CBT-I) must be initiated concurrently with any pharmacotherapy, as it provides superior long-term outcomes with sustained benefits up to 2 years, according to Praxis Medical Insights 5
Sleep hygiene education should include maintaining stable bedtimes and rising times, avoiding daytime napping, caffeine, nicotine, and alcohol, and using the bedroom only for sleep and sex, as recommended by the Journal of the American Geriatrics Society 7

Review all current medications for sleep-disrupting agents, such as β-blockers, bronchodilators, corticosteroids, decongestants, diuretics, SSRIs/SNRIs, which contribute to insomnia, according to Praxis Medical Insights 5
Assess for medical comorbidities, such as cardiac disease, pulmonary disease, osteoarthritis pain, nocturia, and neurologic deficits, which commonly contribute to insomnia in elderly patients, as recommended by Praxis Medical Insights 5

Follow-up every few weeks initially to assess effectiveness, side effects, and ongoing need for medication, according to the Journal of Clinical Sleep Medicine 1, 2, 3
Monitor for next-day impairment, falls, confusion, and behavioral abnormalities, and counsel patients about potential sleep behaviors associated with BzRAs, such as sleepwalking, sleep-driving, and sleep-eating, as recommended by the Journal of Clinical Sleep Medicine 1, 2

Employ the lowest effective maintenance dose and taper medication when conditions allow, according to the Journal of Clinical Sleep Medicine 1, 2, 3
Long-term administration may be nightly, intermittent (3 nights per week), or as-needed depending on symptom pattern, and medication tapering is facilitated by concurrent CBT-I, as recommended by the Journal of Clinical Sleep Medicine 1, 2, 3